/
/
/

Vivanza Biosciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016
₹9 Cr₹6 Cr₹45 Cr₹55 Cr₹9 Cr₹48 L₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹7 Cr₹8 Cr₹9 Cr₹8 Cr₹6 Cr₹1 Cr₹2 Cr₹6 Cr₹2 Cr₹3 Cr₹23 L₹3 Cr₹4 Cr₹2 Cr₹69 L₹6 Cr₹3 Cr₹90,000₹52 L₹1 Cr₹7 L₹22 L₹1 Cr₹1 Cr₹2 Cr₹58 L₹3 Cr₹3 Cr₹48 L₹47 L₹0
₹37 L₹90,000₹8 L₹80,000₹2 L₹5 L₹1 L₹20,000₹30,000-₹3 L₹2 L₹5 L₹1 L₹12 L₹1 L₹29 L₹5 L₹30 L₹2 L₹32 L₹48 L₹10 L₹4 L₹36 L₹30,000₹53 L₹4 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10,000₹4 L₹20,000₹0₹0
₹10 Cr₹6 Cr₹45 Cr₹55 Cr₹9 Cr₹53 L₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹7 Cr₹8 Cr₹9 Cr₹8 Cr₹6 Cr₹2 Cr₹2 Cr₹6 Cr₹2 Cr₹3 Cr₹71 L₹3 Cr₹4 Cr₹3 Cr₹69 L₹6 Cr₹3 Cr₹90,000₹52 L₹1 Cr₹7 L₹22 L₹1 Cr₹1 Cr₹2 Cr₹58 L₹3 Cr₹3 Cr₹48 L₹47 L₹0
₹9 Cr₹7 Cr₹45 Cr₹55 Cr₹9 Cr₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹5 Cr₹6 Cr₹7 Cr₹9 Cr₹8 Cr₹5 Cr₹1 Cr₹2 Cr₹6 Cr₹1 Cr₹3 Cr₹27 L₹3 Cr₹4 Cr₹2 Cr₹85 L₹6 Cr₹3 Cr₹20 L₹61 L₹1 Cr₹21 L₹25 L₹84 L₹1 Cr₹2 Cr₹47 L₹2 Cr₹2 Cr₹68 L₹56 L₹14 L
₹29 L-₹22 L₹29 L₹61 L₹17 L-₹91 L₹13 L₹11 L₹36 L-₹16 L₹31 L₹37 L₹61 L₹12 L₹57 L₹27 L₹18 L₹19 L₹5 L₹36 L₹44 L₹3 L₹28 L₹44 L-₹16 L₹57 L-₹6 L-₹19 L-₹9 L-₹4 L-₹15 L-₹3 L₹19 L₹15 L₹18 L₹11 L₹15 L₹17 L-₹20 L-₹10 L-₹14 L
₹11 L₹7 L₹9 L₹5 L₹8 L₹8 L₹9 L₹9 L₹9 L₹9 L₹10 L₹11 L₹11 L₹11 L₹11 L₹10 L₹10 L₹10 L₹10 L₹10 L₹12 L₹10 L₹11 L₹24 L₹70,000₹8 L₹11 L₹11 L₹13 L₹11 L₹12 L₹10 L₹9 L₹8 L₹10 L₹9 L₹9 L₹4 L₹0₹0₹0
₹18 L-₹30 L₹20 L₹56 L₹9 L-₹99 L₹4 L₹2 L₹26 L-₹27 L₹21 L₹26 L₹49 L₹2 L₹46 L₹17 L₹8 L-₹20 L-₹5 L₹26 L₹32 L-₹8 L₹17 L₹20 L-₹17 L₹49 L-₹17 L-₹31 L-₹22 L-₹15 L-₹26 L-₹12 L₹10 L₹7 L₹8 L₹2 L₹6 L₹13 L-₹20 L-₹10 L-₹14 L
₹15 L-₹45 L₹20 L₹56 L₹9 L-₹100 L₹4 L₹2 L₹26 L-₹41 L₹21 L₹26 L₹49 L-₹10 L₹46 L₹17 L₹8 L-₹20 L-₹5 L₹26 L₹32 L-₹13 L₹17 L₹20 L-₹17 L₹49 L-₹17 L-₹31 L-₹22 L-₹15 L-₹26 L-₹12 L₹10 L₹4 L₹8 L₹2 L₹6 L₹13 L-₹20 L-₹10 L-₹14 L

Share Price Live Stats

Open (₹)1.74
Volume (₹)1,850.00
High (₹)1.80
Upper Circuit2.08
Low (₹)1.74
Lower Circuit1.40
Prev Close1.74
52W High (₹)2.72
Price1.80
52W Low (₹)1.52

Share Market Cap & Key Ratios Overview

M.Cap (₹)6.96 Cr
Div. Yield (%)0.00
PE Ratio15.33
Debt to Equity2.34
Price to Book1.62
Book Value1.09
EPS (TTM)0.11
Face Value1.00
ROE (%)9.48

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
PREMIERENE-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
VIVANZA-XNSE
LTP
1W Low
1W High
Market cap (₹)
2941.55-224.45 (-7.09%)
2831.65
3168
3,90,684Cr
1002.55-11.45 (-1.13%)
995.50
1028.55
45,486Cr
1274.65-14.95 (-1.16%)
1180.45
1327.30
45,144Cr
3747+170.05 (4.75%)
3458.85
3796.35
44,346Cr
368.55+2.7 (0.74%)
343.80
378.95
29,113Cr
480.75+10 (2.12%)
465.25
494
15,566Cr
73.11-0.03 (-0.04%)
69.53
74.50
10,984Cr
344.35-6.65 (-1.89%)
340.85
357.45
7,747Cr
508.3-3.65 (-0.71%)
497.75
529.70
6,238Cr
112.75-2.25 (-1.96%)
110.60
116.95
572Cr
1.8+0.07 (4.05%)
1.70
1.80
7Cr

Key Highlights of Vivanza Biosciences Ltd’s P&L

In 2026-03-31, Vivanza Biosciences Ltd reported total revenue of ₹116.02Cr, compared with ₹7.48Cr in 2025-03-31, reflecting Vivanza Biosciences Ltd turnover.

Depreciation was ₹2.16Lakh and finance costs were ₹28.33Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹54.37Lakh in 2026-03-31 as compared to ₹-₹66.57Lakh in 2025-03-31.

Net Profit (PAT) was ₹39.44Lakh in 2026-03-31 compared with ₹-₹67.41Lakh in 2025-03-31.

Earnings per share (EPS) were ₹0.10 in 2026-03-31, compared with ₹-0.17 in 2025-03-31.